-Cybin Inc. (NYSE American:CYBN / NEO:CYBN), a clinical-stage biopharmaceutical company committed to revolutionizing mental healthcare by developing new...
Welcome to the News You Might Have Missed, a weekly roundup of psychedelic medicine news to help you catch up and stay informed First...
FREMONT, CA, Aug. 07, 2023 (GLOBE NEWSWIRE) — via NewMediaWire – ABVC BioPharma, Inc. (NASDAQ: ABVC)... The post ABVC Corporate Update and CEO’s...
COMPASS Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, reported...
On Monday, publicly-traded psychedelic company Cybin announced an overnight public offering, and its stock paid the price. This came as no surprise to...
The company is operating on a going concern basis. The post Braxia Scientific’s Financial Struggles Overshadow Treatment Successes appeared first on...
Filament Health Corp. (OTCQB: FLHLF / NEO: FH / FSE: 7QS), a clinical-stage natural psychedelic drug development company, is pleased to announce an...
Psyence stretched its fiscal runway and paid off all the debt on its balance sheet. The post Psyence Prepares for Phase 2b Clinical Trial in Australia...
Welcome to the News You Might Have Missed, a weekly roundup of psychedelic medicine news to help you catch up and stay informed The post News...
Top penny stocks to watch with big news this week. The post Top Penny Stocks To Buy? 3 To Watch Before Next Week appeared first on...